Eli Lilly's robust sales for Mounjaro and Zepbound along with its positive outlook for 2025 also work in its favor. Click ...

Jazz Pharmaceuticals JAZZ and Harmony Biosciences HRMY have emerged as notable players in the neuroscience space, especially in the sleep disorder segment. Jazz Pharmaceuticals markets multiple ...

The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

Naloxone will be available for $24 for anyone living in California. The governor's office credited a preliminary decrease in ...

Backed Tinnitus Supplement Aims to Silence Ear Ringing and Restore Cognitive Clarity NaturallyNew York City, April 21, 2025 ...

"Is Lipozem the Ultimate Weight Loss Solution? Verified User Reviews and Clinical Data Reveal Its True Effectiveness in 2025" ...

At Suki, we are dedicated to reducing administrative burdens for clinicians by harnessing the power of AI to streamline workflows. Today, we are thrilled to introduce Ambient Order Staging – an ...

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...

Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...